Labiotech.eu - Europe's leading Biotech News Website

What Did European Oncology Players Offer at ASCO 2020?

How Personal Genomics Companies Are Changing Drug Development

Why Listening to Patient Organizations is Key in Drug Development

Latest News

AI
29/05/2020
AI Drug Discovery Firm Exscientia Closes €54M Series C
Finance
29/05/2020
Argenx Follows up Phase III Success with Giant €785M Global Offering
Brain
29/05/2020
Spanish Neurology Biotech Launches with €7.6M Series A
Cancer
28/05/2020
French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy
Medical
28/05/2020
MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience
Industrial
27/05/2020
‘Just Add Water’ GM Mosquitoes Suppress Wild Population by 95%
Medical
26/05/2020
Argenx’s Rare Disease Treatment Strikes Gold in Phase III

Trending This Month

Top 15 Biotech Companies Driving Innovation in Finland

Will Covid-19 Change the Face of Vaccine Development?

Will Covid-19 Change the Face of Vaccine Development?

What 2019 Can Teach About European Biotech Investments Going Forward

What 2019 Can Teach About European Biotech Investments Going Forward

How Has Coronavirus Affected Europe’s Biotech Stocks?

How Has Coronavirus Affected Europe’s Biotech Stocks?

This category can only be viewed by members. To view this category, sign up by purchasing Labiotech Insider Yearly Membership, Labiotech Insider Company Yearly Membership or Labiotech Insider Monthly Membership.

What Did European Oncology Players Offer at ASCO 2020?

Member Exclusive

This category can only be viewed by members. To view this category, sign up by purchasing Labiotech Insider Yearly Membership, Labiotech Insider Company Yearly Membership or Labiotech Insider Monthly Membership.

Why Listening to Patient Organizations is Key in Drug Development

Member Exclusive

How Are Biotech VC Investments Changing with Covid-19?

Member Exclusive

More Exclusive Content

Refresh London Fireside Chat#2: Exploiting a Niche in Cancer Immunotherapy

How to Solve the Production Challenges of AAVs for Gene Therapy

Sponsored by

Exploring the Evolving Role of CDMOs

Sponsored by

Biotech Money Insider 2020 - Available Now For Insider Members

Refresh Goes Virtual! Register Now!

Refresh Updates

Follow our Coverage of the Coronavirus

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.